Rifampicin Transport by OATP1B1 Variants.

Antimicrobial Agents and Chemotherapy
Carlijn H C LitjensJan B Koenderink

Abstract

Single nucleotide polymorphisms in the OATP1B1 transporter have been suggested to partially explain the large interindividual variation in rifampicin exposure. HEK293 cells overexpressing wild-type (WT) or OATP1B1 variants *1b, *4, *5, and *15 were used to determine the in vitro rifampicin intrinsic clearance. For OATP1B1*5 and *15, a 36% and 42% reduction in intrinsic clearance, respectively, compared to WT was found. We consider that these differences in intrinsic clearance most likely have minor clinical implications.

References

Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephan R VavrickaKarin Fattinger
Dec 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Rommel G TironaRichard B Kim
Feb 7, 2003·The New England Journal of Medicine·William E Evans, Howard L McLeod
Jul 29, 2003·Clinical Pharmacokinetics·Mikko NiemiKari T Kivistö
Apr 22, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc WeinerUNKNOWN Tuberculosis Trials Consortium
Jul 19, 2006·Pharmacogenetics and Genomics·Mikko NiemiMichel Eichelbaum
Dec 25, 2007·Pharmacogenomics·Marja K PasanenMikko Niemi
Apr 21, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yi-Jing HeHong-Hao Zhou
Mar 2, 2010·Nature Reviews. Drug Discovery·UNKNOWN International Transporter ConsortiumLei Zhang
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Marc WeinerAndrew Vernon
May 9, 2012·Molecular Medicine Reports·Ling-Min LiWen-Sheng Chen
Dec 19, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·E van de SteegH M Wortelboer
Feb 6, 2015·American Journal of Respiratory and Critical Care Medicine·Martin J BoereeUNKNOWN PanACEA Consortium
May 27, 2015·The Journal of Infectious Diseases·Helen McIlleronAndrew Owen
Dec 15, 2015·Annals of the American Thoracic Society·John F MurrayPhilip C Hopewell

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.